Gregory V. Varallo focuses his practice on complex corporate and business litigation, corporate governance and corporate transactions. He has litigated numerous complex business disputes in the Delaware courts and has also appeared on behalf of the firm's clients in state and federal courts throughout the United States. Greg is a director in the firm and vice chair of the Corporate Department.
A frequent author and speaker at numerous seminars and institutes, Greg has been published in The Business Lawyer, The Securities Regulation Law Journal, M&A Lawyer, Corporate Governance Advisor, Insights and Business Law Today. He has been a panelist at the annual Securities Regulation Law Institute (PLI), as well as various PLI, ABA and other programs and institutes.
Representative Experience
Significant matters in which Greg has served as lead counsel or co-lead counsel include:
- Lead counsel in first confidential Chancery arbitrations
- Lead counsel for the tobacco industry in Delaware in connection with the entry of the landmark consent decree between that industry and the state attorneys general
- PL Capital, LLC v. Central Bancorp, Inc., No. 03-0554 BLS, Van Gestle, J. (Mass. Super. June 30, 2003), in which the client succeeded in enjoining and then defeating the first attempted use of the "poison pill" or stockholder rights plan against a stockholder
- Lead counsel in Frontier v. Holly, 2005 WL 1039027 (Del. Ch.), where the court concluded that the filing of mass tort litigation in California was not a "material adverse effect" under a merger agreement
- Teleglobe v. BCE, Inc., Adv. Pro. No. 04-53733 (MFW), mediated settlement for client after five years of litigation in the federal courts resulting in $40 million cash and more than $500 million in claims waived
- Selectica, Inc. v. Versata Enterprises, Inc. and Trilogy, Inc., 2010 WL 703062 (Del. Ch. Feb. 26, 2010), aff'd, 5 A.3d 586 (Del. Oct. 4, 2010), successful lead trial and appellate counsel in case involving first actual use of poison pill rights plan